University of California, San Francisco.
Legacy Tobacco Documents Library.
Basic Search Advanced Search Expert Search Bookbag Search History Preferences

Trial testimony of MICHAEL CHRISTOPHER FIORE, M.D....

Title Trial testimony of MICHAEL CHRISTOPHER FIORE, M.D., M.P.H., May 18, 2005, UNITED STATES OF AMERICA v. PHILIP MORRIS USA INC.
Document Date 20050518 (May 18, 2005)
Document Type Trial Testimony
Bates Number Previous Bates FIOREM051805 Next Bates
Collection DATTA
Topic advertising; cessation products; economic activity; smoking cessation; smoking cessation rates
Pages 84
Organizations Mentioned American Cancer Society; American Legacy Foundation; Elan Pharmaceutical; Free and Clear; GlaxoSmithKline; Group Health Cooperative; National Institutes of Health; North American Quit Line Consortium; Pfizer International; Robert Wood Johnson Foundation; Roswell Park Cancer Institute; Sanofi; United States Department of Health and Human Services; United States Centers for Disease Control and Prevention; University of Wisconsin
Persons Mentioned Burns, David Michael, M.D.; Carmona, Richard H.; Davis, Ronald Mark, M.D.; Delano, Richard; Healton, Cheryl G.; Koh, Howard K.; McAfee, Dr.; Reed, Robert M., D.D.S.; Reister, Tim; Shelton, Dana; Zhu, Shu Hong
Description The plaintiff's expert witness, an expert in smoking cessation, continued to testify. He explained how he arrived at his estimates of how many smokers would use a National Quit Line and how many would be successful in quitting. He described how the Group Health Cooperative’s Free and Clear program use these figures in establishing a cost model that estimated the costs associated with implementing a national comprehensive Quit Line. He discussed the methodology that was used to arrive at the estimate of a one billion dollar cost for a national advertising campaign. He reviewed the costs associated with supplying smokers with nicotine gum. The witness discussed studies that have been done of the cost effectiveness of current quit lines and cessation programs. He explained why it is so important to eliminate the barriers that hamper these programs. He indicated that when people are given access to a well-integrated, systematized comprehensive resource that utilization rates go up.
Case Name United States of America v. Philip Morris U.S.A. Inc.
Date Added UCSF 20071206 (December 6, 2007)
Witness Fiore, Michael C., M.D., M.P.H. (affiliation: University of Wisconsin Department of Medicine; expertise: Nicotine Addiction; job_title: Director of Tobacco Research and Intervention Program; side: Plaintiff; witness_type: Expert)
TID wnk79a00

Add to Bookbag
View as PDF document
View as TIFF image
View page-by-page
http://legacy.library.ucsf.edu/tid/wnk79a00

UCSF Library   Contact Us | Copyright and Fair Use | Privacy | Site Map | Sponsors | UCSF Tobacco Archives American Legacy Foundation

University of California, San Francisco ©2007 The Regents of the University of California